These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38566191)

  • 21. MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation.
    Zhang XY; Dai HP; Zhang L; Liu SN; Dai Y; Wu DP; Tang XW
    Onco Targets Ther; 2021; 14():5197-5204. PubMed ID: 34744437
    [No Abstract]   [Full Text] [Related]  

  • 22. ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.
    Dickerson KM; Qu C; Gao Q; Iacobucci I; Gu Z; Yoshihara H; Backhaus EA; Chang Y; Janke LJ; Xu B; Wu G; Papachristou EK; D'Santos CS; Roberts KG; Mullighan CG
    Blood Cancer Discov; 2022 May; 3(3):240-263. PubMed ID: 35247902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
    Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Identification of TCF3-ZNF384 fusion by transcriptome sequencing in B cell acute lymphoblastic leukemia and its laboratory and clinical characteristics].
    Wu Q; Wang F; Yang J; Chen X; Ma X; Cao P; Zhang Y; Nie D; Chen J; Zhou X; Fang J; Liu M; Zhang M; Wu P; Wang T; Liu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Apr; 38(4):351-354. PubMed ID: 33834463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.
    Yamamoto K; Kawamoto S; Mizutani Y; Yakushijin K; Yamashita T; Nakamachi Y; Kawano S; Hayashi Y; Matsuoka H; Minami H
    Cytogenet Genome Res; 2016; 149(3):165-170. PubMed ID: 27607436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
    Liu YF; Wang BY; Zhang WN; Huang JY; Li BS; Zhang M; Jiang L; Li JF; Wang MJ; Dai YJ; Zhang ZG; Wang Q; Kong J; Chen B; Zhu YM; Weng XQ; Shen ZX; Li JM; Wang J; Yan XJ; Li Y; Liang YM; Liu L; Chen XQ; Zhang WG; Yan JS; Hu JD; Shen SH; Chen J; Gu LJ; Pei D; Li Y; Wu G; Zhou X; Ren RB; Cheng C; Yang JJ; Wang KK; Wang SY; Zhang J; Mi JQ; Pui CH; Tang JY; Chen Z; Chen SJ
    EBioMedicine; 2016 Jun; 8():173-183. PubMed ID: 27428428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12).
    Nyquist KB; Thorsen J; Zeller B; Haaland A; Trøen G; Heim S; Micci F
    Cancer Genet; 2011 Mar; 204(3):147-52. PubMed ID: 21504714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL3RA-Targeting Antibody-Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies.
    Kirchhoff D; Stelte-Ludwig B; Lerchen HG; Wengner AM; Ahsen OV; Buchmann P; Märsch S; Mahlert C; Greven S; Dietz L; Erkelenz M; Zierz R; Johanssen S; Mumberg D; Sommer A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukemia With
    Lin N; Yan X; Cai D; Wang L
    Front Oncol; 2021; 11():709036. PubMed ID: 34395283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel class of ZNF384 aberrations in acute leukemia.
    Zaliova M; Winkowska L; Stuchly J; Fiser K; Triska P; Zwyrtkova M; Hrusak O; Starkova J; Sramkova L; Stary J; Trka J; Zuna J
    Blood Adv; 2021 Nov; 5(21):4393-4397. PubMed ID: 34529760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells.
    Agger K; Miyagi S; Pedersen MT; Kooistra SM; Johansen JV; Helin K
    Genes Dev; 2016 Jun; 30(11):1278-88. PubMed ID: 27257215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
    Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
    Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Significance of
    Qin YZ; Jiang Q; Xu LP; Wang Y; Jiang H; Dao FT; Chen WM; Zhao XS; Liu YR; Zhang XH; Liu KY; Huang XJ
    Front Oncol; 2021; 11():632532. PubMed ID: 33816270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.
    Huang Y; Mouttet B; Warnatz HJ; Risch T; Rietmann F; Frommelt F; Ngo QA; Dobay MP; Marovca B; Jenni S; Tsai YC; Matzk S; Amstislavskiy V; Schrappe M; Stanulla M; Gstaiger M; Bornhauser B; Yaspo ML; Bourquin JP
    Cancer Cell; 2019 Dec; 36(6):630-644.e9. PubMed ID: 31735627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Adult Patient with Early Pre-B Acute Lymphoblastic Leukemia with t(12;17)(p13;q21)/ZNF384-TAF15.
    Georgakopoulos N; Diamantopoulos P; Micci F; Giannakopoulou N; Zervakis K; Dimitrakopoulou A; Viniou NA
    In Vivo; 2018; 32(5):1241-1245. PubMed ID: 30150451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute lymphoblastic leukemia with infrequent ARID1B::ZNF384 gene fusion simulating multifocal osteomyelitis.
    Long F; Li T; Zhang Y; Gao X; Wang H; Huang X
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30514. PubMed ID: 37336773
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.
    Chiaretti S; Taherinasab A; Della Starza I; Canichella M; Ansuinelli M; De Propris MS; Messina M; Spinelli O; Santoro A; De Novi LA; Cardinali D; Schipani M; Arena V; Bassan R; Guarini A; Foà R
    Leuk Lymphoma; 2023 Feb; 64(2):483-486. PubMed ID: 36533589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.